Eupraxia Pharmaceuticals Stock Alpha and Beta Analysis
| EPRXF Stock | USD 3.01 0.01 0.33% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eupraxia Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eupraxia Pharmaceuticals over a specified time horizon. Remember, high Eupraxia Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eupraxia Pharmaceuticals' market risk premium analysis include:
Beta (0.41) | Alpha (0.20) | Risk 6.67 | Sharpe Ratio (0.02) | Expected Return (0.12) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Eupraxia |
Eupraxia Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eupraxia Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eupraxia Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eupraxia Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eupraxia Pharmaceuticals' performance over market.| α | -0.2 | β | -0.41 |
Eupraxia Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Eupraxia Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Eupraxia Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Eupraxia Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By understating and applying Eupraxia Pharmaceuticals pink sheet market price indicators, traders can identify Eupraxia Pharmaceuticals position entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Return and Market Media
The median price of Eupraxia Pharmaceuticals for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 is 3.79 with a coefficient of variation of 24.86. The daily time series for the period is distributed with a sample standard deviation of 0.98, arithmetic mean of 3.94, and mean deviation of 0.87. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Eupraxia Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eupraxia or other pink sheets. Alpha measures the amount that position in Eupraxia Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eupraxia Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eupraxia Pharmaceuticals' short interest history, or implied volatility extrapolated from Eupraxia Pharmaceuticals options trading.
Build Portfolio with Eupraxia Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Eupraxia Pharmaceuticals Backtesting, Eupraxia Pharmaceuticals Valuation, Eupraxia Pharmaceuticals Correlation, Eupraxia Pharmaceuticals Hype Analysis, Eupraxia Pharmaceuticals Volatility, Eupraxia Pharmaceuticals History and analyze Eupraxia Pharmaceuticals Performance. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Eupraxia Pink Sheet analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Eupraxia Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.